126 related articles for article (PubMed ID: 20881392)
1. D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy.
Sadanaga T; Kohsaka S; Ogawa S
Cardiology; 2010; 117(1):31-6. PubMed ID: 20881392
[TBL] [Abstract][Full Text] [Related]
2. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
3. Soluble fibrin monomer complex levels during oral anticoagulant therapy do not predict subsequent thromboembolic events in patients with permanent atrial fibrillation.
Sadanaga T; Mitamura H
Int J Cardiol; 2013 Sep; 168(1):578-80. PubMed ID: 23465239
[No Abstract] [Full Text] [Related]
4. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.
Sadanaga T; Sadanaga M; Ogawa S
J Am Coll Cardiol; 2010 May; 55(20):2225-31. PubMed ID: 20466203
[TBL] [Abstract][Full Text] [Related]
5. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
Cevik C; Otahbachi M; Nugent K; Ozkan M
J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
[TBL] [Abstract][Full Text] [Related]
6. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
Watson T; Shantsila E; Lip GY
Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
[No Abstract] [Full Text] [Related]
7. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
10. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
13. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
Vene N; Mavri A; Kosmelj K; Stegnar M
Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
[TBL] [Abstract][Full Text] [Related]
14. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
[TBL] [Abstract][Full Text] [Related]
15. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
16. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.
Ombandza-Moussa E; Samama MM; Horellou MH; Elalamy I; Conard J
Int Angiol; 2003 Dec; 22(4):364-9. PubMed ID: 15153820
[TBL] [Abstract][Full Text] [Related]
17. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.
Habara S; Dote K; Kato M; Sasaki S; Goto K; Takemoto H; Hasegawa D; Matsuda O
Eur Heart J; 2007 Sep; 28(18):2217-22. PubMed ID: 17716991
[TBL] [Abstract][Full Text] [Related]
18. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis.
Wu N; Chen X; Cai T; Wu L; Xiang Y; Zhang M; Li Y; Song Z; Zhong L
Can J Cardiol; 2015 Mar; 31(3):278-86. PubMed ID: 25746020
[TBL] [Abstract][Full Text] [Related]
19. Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation.
Sadanaga T; Kohsaka S; Mitamura H; Ogawa S
Heart Vessels; 2011 Sep; 26(5):530-5. PubMed ID: 21188387
[TBL] [Abstract][Full Text] [Related]
20. Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.
Tay KH; Khoo CW; Lip GY
J Heart Valve Dis; 2009 May; 18(3):276-7. PubMed ID: 19557982
[No Abstract] [Full Text] [Related]
[Next] [New Search]